-
Merrimack Pharmaceuticals Inc
One Kendall Square
Cambridge,
MA 02139
United States
-
Company News
Price
- Last Close
-
$ 11.74
0 %
+0.09
Dec 9, 2022
- Trading Volume
- 54,400
- 52-Week High/Low
- $7.13 - $3.75
- Market Cap Full
- $ 75.7M
- YTD
- 0%
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | - | 61.8% | -8.9% | -5% | 80.1% | -21.5% | -24.5% | 6% | 5.1% | -5.5% |
| Q2 | - | -5.9% | 1.8% | 4% | -17.5% | -36.7% | -40.8% | -35.6% | 4.1% | 44.7% |
| Q3 | - | -37% | -24.4% | 8% | -21.1% | 7.2% | 17.3% | 17.8% | -31.2% | 20.5% |
| Q4 | - | 213.1% | -19.1% | 72.3% | -30.4% | -26.9% | -31.2% | -35.8% | -7.2% | 28.7% |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | - | - | - | - | - | - | - | - | - | - | - | - |
| 2022 | 32.5% | 20.5% | 1.4% | -8.3% | -10.7% | 14.9% | -14.5% | -18.5% | -9.6% | 0.5% | 215.9% | -1.4% |
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0% | 200% | -43% | 115% | -17% | -62% | -63% | -48% | -30% | 112% | -12% |
Earnings
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | -0.05 | 0.02 | -0.78 | -1.33 | 0.22 | 0.33 | 0.32 | -2.70 | -2.90 | -21.40 |
| Q2 | -0.06 | -0.09 | -0.71 | -1.33 | 0.22 | 0.40 | 0.21 | -1.70 | -3.10 | -2.20 |
| Q3 | -0.04 | -0.08 | -0.05 | 0.3 | 0.40 | 0.23 | 0.38 | -2.70 | -3.90 | -2.50 |
| Q4 | - | -0.08 | 0.24 | -0.67 | 0.89 | 0.25 | 0.41 | -0.90 | -3.30 | 13.30 |
| A | -0.1 |
Annual Returns
52 Week
High/Low
Quarterly Earnings
Annual
Earnings
Trading Volume
| 2019 | |
|---|---|
| Q1 | 1.49668 |
| Q2 | 0.50074 |
| Q3 | - |
| Q4 | - |
| A | 1.99742 |